David A. Siegel Bio N Tech Se Transaction History

Two Sigma Advisers, LP

  • $46.1 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$85.73 - $119.5 $15.9 Million - $22.2 Million
-185,361 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$72.71 - $129.54 $10.1 Million - $17.9 Million
138,400 Added 294.71%
185,361 $15.1 Million
Q3 2020

Nov 16, 2020
BUY
$57.81 - $104.17 $2.71 Million - $4.89 Million
46,961 New
46,961 $3.25 Million

Others Institutions Holding BNTX

# of Institutions
312
Shares Held
42.6M
Call Options Held
1.27M
Put Options Held
1.26M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $25.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email